Hackers could take control of medical devices, McAfee warnsResearch published by cyber security company, McAfee, shows it is possible to modify real-time patient heart monitor data Share XHackers could take control of medical devices, McAfee warnshttps://pharmaphorum.com/news/mcafee-hacks-vital-medical-equipment/
HIV drug cuts viral load, boosts immunity in Yale studyA Yale University study has found ibalizumab reduced viral replication and increased the count of immune cells in Share XHIV drug cuts viral load, boosts immunity in Yale studyhttps://pharmaphorum.com/news/ibalizumab-cuts-hiv-viral-load/
Regeneron/Teva pain drug fasinumab on target in phase 3Pfizer and Eli Lilly are competitors in NGF research Share XRegeneron/Teva pain drug fasinumab on target in phase 3https://pharmaphorum.com/news/regeneron-teva-pain-drug-fasinumab-target-phase-3/
Innovation and collaboration: key catalysts for scientific break-throughsDuring my time at Illumina I had a realisation: restricted access to data, and an industry-wide aversion to Share XInnovation and collaboration: key catalysts for scientific break-throughshttps://pharmaphorum.com/views-and-analysis/innovation-collaboration-key-catalysts-scientific-break-throughs/
The power of blockchain in cancer care transformationOver the course of the last decade blockchain technology has slowly filtered through from the underground to the Share XThe power of blockchain in cancer care transformationhttps://pharmaphorum.com/views-and-analysis/blockchain-power-cancer-care/
Beyond patient centricity – supporting the support networkOur new patient-centric world has already gone “beyond the pill”, and now it’s going beyond the patient. There’s a Share XBeyond patient centricity – supporting the support networkhttps://pharmaphorum.com/views-and-analysis/beyond-patient-centricity-support-network/
CAR-Ts – a new weapon in the fight against cancerCAR-T – or Chimeric Antigen Receptor T-cell therapies herald a new wave of therapies in cancer. CAR-T therapies Share XCAR-Ts – a new weapon in the fight against cancerhttps://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/
How to achieve digital success in pharma’s communicationsDemystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for Share XHow to achieve digital success in pharma’s communicationshttps://pharmaphorum.com/views-analysis-digital/achieve-digital-success-pharma/
Future-proofing pharma with a multichannel approach to sales and marketingDeploying a multichannel approach to marketing, backed by the use of advanced analytics, could help pharma evolve and Share XFuture-proofing pharma with a multichannel approach to sales and marketinghttps://pharmaphorum.com/views-analysis-sales-marketing/multichannel-marketing-sales-pharma/
How to make digital work in medtech Share XHow to make digital work in medtechhttps://pharmaphorum.com/webinars/webinars-on-demand/make-digital-work-medtech/
Engaging with HCPS: what do HCPs want from medical meetings? Share XEngaging with HCPS: what do HCPs want from medical meetings?https://pharmaphorum.com/webinars/webinars-on-demand/engaging-with-hcps-what-do-hcps-want-from-medical-meetings/
04/12/2018UK pharma and integrated health Share XUK pharma and integrated healthhttps://pharmaphorum.com/debates-insight-sales-marketing/uk-pharma-integrated-health/
The changing face of pharmaceutical launchesThe industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues Share XThe changing face of pharmaceutical launcheshttps://pharmaphorum.com/market-access-2/digital-transforming-pharmaceutical-launches/
Remote HCP engagement – still a struggle for life science companiesLife science companies are failing to achieve their full digital potential, particularly when it comes to the use Share XRemote HCP engagement – still a struggle for life science companieshttps://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/
Medical meetings and what HCPs wantThe healthcare professional (HCP) meeting landscape is evolving, but even as it adjusts to the demands of the Share XMedical meetings and what HCPs wanthttps://pharmaphorum.com/whitepapers/medical-meetings-and-what-hcps-want/
Raising the bar in liver cancer therapy Share XRaising the bar in liver cancer therapyhttps://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/
Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success Share XEisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s successhttps://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/
Part three: Oncology shaping the future of personalised healthcare Share XPart three: Oncology shaping the future of personalised healthcarehttps://pharmaphorum.com/video/part-three-oncology-shaping-future-personalised-healthcare/
Event Highlights for 13th Annual Industry Leading Cold Chain Distribution 2018 Share XEvent Highlights for 13th Annual Industry Leading Cold Chain Distribution 2018https://pharmaphorum.com/partner-content/event-highlights-for-13th-annual-industry-leading-cold-chain-distribution-2018/
Insightful Developments and an Exclusive Interview from Roche Share XInsightful Developments and an Exclusive Interview from Rochehttps://pharmaphorum.com/partner-content/insightful-developments-and-an-exclusive-interview-from-roche/
Invitation from Chair of this year’s Immuno-Oncology Conference in London Share XInvitation from Chair of this year’s Immuno-Oncology Conference in Londonhttps://pharmaphorum.com/partner-content/invitation-from-chair-of-this-years-immuno-oncology-conference-in-london/
Your Exclusive Invitation from the Chair for Cell & Gene Therapy 2018 Share XYour Exclusive Invitation from the Chair for Cell & Gene Therapy 2018https://pharmaphorum.com/partner-content/your-exclusive-invitation-from-the-chair-for-cell-gene-therapy-2018/
Medmeme appoints senior strategist for Europe Share XMedmeme appoints senior strategist for Europehttps://pharmaphorum.com/partner-content/medmeme-appoints-senior-strategist-for-europe/
Betsy Bondurant joins 3Sixty Event Consulting to lead US operations Share XBetsy Bondurant joins 3Sixty Event Consulting to lead US operationshttps://pharmaphorum.com/partner-content/appointments/betsy-bondurant-joins-3sixty-event-consulting-to-lead-us-operations/
